TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Rogers Corp Lead
Play
INVESTING

Rogers Corp., Axos Financial: 5 Top Stock Gainers

  • By Rob Lenihan
  • Oct 30, 2020 4:22 PM EDT
PRESS RELEASES

FDA Grants Priority Review To Genentech's Esbriet (pirfenidone) For Unclassifiable Interstitial Lung Disease

  • By Business Wire
  • Jan 21, 2021 1:00 AM EST
PRESS RELEASES

Genentech's Novel Anti-TIGIT Tiragolumab Granted FDA Breakthrough Therapy Designation In Combination With Tecentriq For PD-L1-High Non-Small Cell Lung Cancer

  • By Business Wire
  • Jan 5, 2021 1:00 AM EST
PRESS RELEASES

Genentech's Faricimab Meets Primary Endpoint And Shows Strong Durability Across Two Global Phase III Studies For Diabetic Macular Edema, A Leading Cause Of Blindness

  • By Business Wire
  • Dec 21, 2020 1:00 AM EST
PRESS RELEASES

Genentech Announces New Data Reinforcing The Long-Term Benefit Of Venclexta-Based Combination For People With Relapsed Or Refractory Chronic Lymphocytic Leukemia

  • By Business Wire
  • Dec 5, 2020 12:45 PM EST
PRESS RELEASES

Rogers Corporation Appoints Megan Faust And Keith Larson To Its Board Of Directors

  • By Business Wire
  • Dec 3, 2020 12:00 PM EST
PRESS RELEASES

Genentech Announces FDA Approval Of Gavreto (pralsetinib) For People With Advanced Or Metastatic RET-Mutant And RET Fusion-Positive Thyroid Cancers

  • By Business Wire
  • Dec 1, 2020 3:15 PM EST
PRESS RELEASES

Genentech Announces FDA Approval Of Xolair (omalizumab) For Adults With Nasal Polyps

  • By Business Wire
  • Dec 1, 2020 11:34 AM EST
PRESS RELEASES

Genentech Announces FDA Approval Of Xofluza For The Prevention Of Influenza Following Contact With An Infected Person

  • By Business Wire
  • Nov 23, 2020 2:46 PM EST
PRESS RELEASES

OneOncology Partners With Genentech To Bring Personalized Cancer Research To Patients At Community Oncology Sites

  • By PR Newswire
  • Nov 23, 2020 6:15 AM EST
PRESS RELEASES

Leading Diagnostics Companies Join Forces To Establish The Access To Comprehensive Genomic Profiling Coalition (ACGP)

  • By PR Newswire
  • Nov 17, 2020 8:00 AM EST
Rogers Corp Lead
INVESTING

Rogers Corp., Axos Financial: 5 Top Stock Gainers

  • By Rob Lenihan
  • Oct 30, 2020 4:22 PM EDT
PRESS RELEASES

Rogers Schedules Q3 2020 Earnings Call For October 29, 2020

  • By Business Wire
  • Oct 20, 2020 3:39 PM EDT
PRESS RELEASES

Genentech Announces Full FDA Approval For Venclexta Combinations For Acute Myeloid Leukemia

  • By Business Wire
  • Oct 16, 2020 7:30 PM EDT
PRESS RELEASES

Genentech Presents New 2-Year Data For Evrysdi (risdiplam) In Infants With Type 1 Spinal Muscular Atrophy (SMA)

  • By Business Wire
  • Sep 28, 2020 1:00 AM EDT
PRESS RELEASES

Inflazome Announces Acquisition By Roche

  • By Business Wire
  • Sep 21, 2020 2:00 AM EDT
PRESS RELEASES

Genentech Presents New Data From Multiple Phase III Studies Of Tecentriq In Triple-Negative Breast Cancer At ESMO Virtual Congress 2020

  • By Business Wire
  • Sep 19, 2020 10:20 AM EDT
PRESS RELEASES

Genentech's Phase III EMPACTA Study Showed Actemra Reduced The Likelihood Of Needing Mechanical Ventilation In Hospitalized Patients With COVID-19 Associated Pneumonia

  • By Business Wire
  • Sep 18, 2020 1:00 AM EDT
PRESS RELEASES

New Data Further Reinforce Genentech's Ocrevus (ocrelizumab) As A Highly Effective Treatment For People With Multiple Sclerosis

  • By Business Wire
  • Sep 11, 2020 1:00 AM EDT
PRESS RELEASES

New Data Show Genentech's Enspryng Significantly Reduces Severity And Risk Of Relapse In Neuromyelitis Optica Spectrum Disorder

  • By Business Wire
  • Sep 10, 2020 1:00 AM EDT
PRESS RELEASES

Genentech Expands Its Multiple Sclerosis Portfolio With Investigational BTK Inhibitor Fenebrutinib And Initiates Novel Clinical Trials For Ocrevus (ocrelizumab)

  • By Business Wire
  • Sep 9, 2020 1:00 AM EDT
PRESS RELEASES

Genentech Announces FDA Approval Of Gavreto (pralsetinib) For The Treatment Of Adults With Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

  • By Business Wire
  • Sep 4, 2020 7:00 PM EDT
PRESS RELEASES

Genentech And Regeneron Collaborate To Significantly Increase Global Supply Of REGN-COV2 Investigational Antibody Combination For COVID-19

  • By Business Wire
  • Aug 19, 2020 1:00 AM EDT
PRESS RELEASES

 FDA Approves Genentech's Enspryng For Neuromyelitis Optica Spectrum Disorder

  • By Business Wire
  • Aug 14, 2020 10:30 PM EDT
PRESS RELEASES

Genentech Provides Update On Phase III Studies Of Etrolizumab In People With Moderately To Severely Active Ulcerative Colitis

  • By Business Wire
  • Aug 10, 2020 1:00 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.